In the News


Latest COVID-19 studies identify predictors of poor outcomes, neurologic manifestations

Data from China provide new insights into disease characteristics, experts offer advice on caring for isolated older adults, and ACP and others release guidance on easing social distancing and other restrictions.

One-third of primary care physicians do not support medications for opioid use disorder

Fewer than a quarter of surveyed primary care physicians expressed interest in treating patients with opioid use disorder, and only 11.8% were interested in obtaining a waiver to prescribe buprenorphine.

MKSAP Quiz: 2-month history of a burning sensation

A 45-year-old man is evaluated for a 2-month history of a burning sensation starting in his stomach and radiating into his chest, usually occurring 4 to 5 times weekly. He says that he usually eats dinner late and then goes to sleep. He often wakes up with a sour taste in his mouth. Following a physical exam, which is the most appropriate next step in management?

Clinical practice guideline released on pharmacologic management of COPD

The American Thoracic Society strongly recommended LABA/LAMA combination therapy over monotherapy with either agent in patients with chronic obstructive pulmonary disease (COPD) and dyspnea or exercise intolerance, among other guidance.

ACP's Annual Business Meeting and Town Hall webinar set for April 25

Incoming Officers, new Regents, and first-year Governors will be introduced, and the Treasurer, 2019-2020 President, and 2020-2021 President will report on the College's current status and priorities.

Remote monitoring successfully replaced some visits in post-MI care, study finds

Patients in the study's intervention group were given four smartphone-compatible devices: a scale, a blood pressure monitor, a heart rhythm monitor, and a step counter.

Put words in our mouth

ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.